CONSULTING AND INTERIM CHIEF FINANCIAL OFFCER AGREEMENTInterim Chief Financial Offcer Agreement • June 15th, 2020 • Mereo Biopharma Group PLC • Pharmaceutical preparations • New York
This Consulting and Interim Chief Financial Officer Agreement (“Agreement”) is effective as of the 14th day of May, 2020 by and among Mereo BioPharma Group plc, a company incorporated in England and Wales with a registered office at 1 Cavendish Place, London W1G 0QF (the “Company”), MSW Consulting Inc., a corporation with headquarters located at 49 Beacon Street, Unit 3 Boston, MA 02108 (“Consultant”), and Michael Wyzga (”Wyzga” or “Executive”).
Michael S Wyzga Dear MikeMereo Biopharma Group PLC • June 15th, 2020 • Pharmaceutical preparations
Letter of appointment between (1) Mereo BioPharma Group plc (the “Company”) and (2) Mike Wyzga (“you”) dated 23 April 2019 (the “Appointment Letter”)
SETTLEMENT AGREEMENTMereo Biopharma Group PLC • June 15th, 2020 • Pharmaceutical preparations • England and Wales
